Log In
Print this Print this

Gliadel, Gliadel Wafer, carmustine implant (NPC-08)

Also known as: polifeprosan 20 with carmustine implant

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionBiodegradable polymer implant containing carmustine
Molecular Target DNA
Mechanism of ActionBreaks/crosslinks DNA
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationBrain cancer
Indication DetailsAdjunct to surgery in patients with recurrent glioblastoma multiforme (GBM); First-line treatment for malignant glioma; Initial surgery for high-grade malignant glioma; Initial surgery for malignant glioma; Treat brain cancer; Treat glioblastoma brain tumor; Treat high-grade malignant glioma; Treat malignant glioblastoma multiforme (GBM); Treat malignant glioma; Treat metastatic brain cancer; Treat newly diagnosed malignant glioma; Treat patients with malignant glioma undergoing primary surgical resection; Treat primary glioblastoma multiforme (GBM); Treat recurrent glioblastoma multiforme (GBM); Treat recurrent glioma
Regulatory Designation
Partner Arbor Pharmaceuticals Inc.; BioPro Pharmaceutical Inc.; Nobelpharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today